LIAISON® FPSA - COFEPRIS Registration 1241R2018 SSA
Access comprehensive regulatory information for LIAISON® FPSA (FPSA LINK®) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1241R2018 SSA and manufactured by DIASORIN MÉXICO, S.A. DE C.V.. The device was registered on May 30, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ENSAYO IN VITRO PARA DETERMINACIÓN CUANTITATIVA DE ANTÍGENO PROSTÁTICO ESPECÍFICO LIBRE (FPSA) EN SUERO O PLASMA HUMANOS (CON EDTA O HEPARINIZADO). LA PRUEBA DEBE REALIZARSE EN LA SERIE DE INSTRUMENTOS LIAISON® ANALYZER.
IN VITRO ASSAY FOR QUANTITATIVE DETERMINATION OF FREE PROSTATE-SPECIFIC ANTIGEN (FPSA) IN HUMAN SERUM OR PLASMA (WITH EDTA OR HEPARINIZED). THE TEST SHOULD BE PERFORMED ON THE LIAISON® ANALYZER INSTRUMENT SERIES.